- Home
- MMT vs FENC Comparison
MMT vs FENC Comparison
Compare MMT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMT | FENC |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.4M | 230.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | MMT | FENC |
|---|---|---|
| Price | $4.48 | $9.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 112.3K | ★ 239.5K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 8.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | $14.96 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.37 | $5.65 |
| 52 Week High | $4.87 | $10.17 |
Technical Indicators
Market Signals| Indicator | MMT | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 76.69 |
| Support Level | $4.37 | $7.49 |
| Resistance Level | $4.72 | $9.92 |
| Average True Range (ATR) | 0.05 | 0.57 |
| MACD | -0.01 | 0.30 |
| Stochastic Oscillator | 5.26 | 87.13 |
Price Performance
Historical ComparisonAbout MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, automotive, chemicals, electronics, and others.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.